[EFFECT] SeaStar Medical Holding Corporation SEC Filing
SeaStar Medical Holding Corp (ICU) has received a formal Notice of Effectiveness from the U.S. Securities and Exchange Commission, confirming that the company鈥檚 Form S-1 registration statement (File No. 333-288065) became effective on June 20 2025 at 12:00 p.m. ET. The effectiveness marks the final regulatory step required before the company may use the registration statement for activities described therein, such as issuing or reselling securities. No additional financial metrics, transaction details, or offering terms were included in this notice.
SeaStar Medical Holding Corp (ICU) ha ricevuto una formale Notifica di Efficacia dalla Securities and Exchange Commission degli Stati Uniti, che conferma che la dichiarazione di registrazione Form S-1 della societ脿 (File No. 333-288065) 猫 diventata efficace il 20 giugno 2025 alle 12:00 p.m. ET. Questa efficacia rappresenta l'ultimo passaggio regolamentare necessario prima che la societ脿 possa utilizzare la dichiarazione di registrazione per le attivit脿 descritte, come l'emissione o la rivendita di titoli. Nessuna metrica finanziaria aggiuntiva, dettagli della transazione o termini dell'offerta sono stati inclusi in questa notifica.
SeaStar Medical Holding Corp (ICU) ha recibido una Notificaci贸n de Efectividad formal de la Comisi贸n de Bolsa y Valores de EE. UU., confirmando que la declaraci贸n de registro Formulario S-1 de la compa帽铆a (Archivo No. 333-288065) se hizo efectiva el 20 de junio de 2025 a las 12:00 p.m. ET. La efectividad marca el 煤ltimo paso regulatorio necesario antes de que la empresa pueda utilizar la declaraci贸n de registro para las actividades descritas, como emitir o revender valores. No se incluyeron m茅tricas financieras adicionales, detalles de la transacci贸n ni t茅rminos de la oferta en esta notificaci贸n.
SeaStar Medical Holding Corp (ICU)電� 氙戈淡 歃濌秾瓯半灅鞙勳洂須�(SEC)搿滊秬韯� 瓿奠嫕鞝侅澑 須牓 韱奠靹�毳� 氚涭晿鞙茧┌, 須岇偓鞚� Form S-1 霌彪 靹滊(韺岇澕 氩堩樃 333-288065)臧� 2025雲� 6鞗� 20鞚� 鞓ろ泟 12鞁�(霃欕秬鞁滉皠)鞐� 須牓鞚� 氚滌儩頄堨潓鞚� 頇曥澑頄堨姷雼堧嫟. 鞚� 須牓 氚滌儩鞚� 須岇偓臧� 頃措嫻 霌彪 靹滊鞐� 氇呾嫓霅� 頇滊彊, 鞓堧ゼ 霌れ柎 歃濌秾 氚滍枆 霕愲姅 鞛寪毵るゼ 歆勴枆頃橁赴 鞝勳棎 頃勳殧頃� 斓滌 攴滌牅 鞝堨皑毳� 鞚橂頃╇媹雼�. 鞚� 韱奠靹滌棎電� 於旉皜 鞛 歆�響�, 瓯半灅 靹鸽秬靷暛 霕愲姅 瓿惦 臁瓣贝鞚� 韽暔霅橃 鞎婌晿鞀惦媹雼�.
SeaStar Medical Holding Corp (ICU) a re莽u une Notification d鈥橢fficacit茅 officielle de la Securities and Exchange Commission des 脡tats-Unis, confirmant que la d茅claration d鈥檈nregistrement Formulaire S-1 de la soci茅t茅 (Dossier n掳 333-288065) est devenue effective le 20 juin 2025 脿 12h00 ET. Cette efficacit茅 marque l鈥櫭﹖ape r茅glementaire finale requise avant que la soci茅t茅 puisse utiliser la d茅claration d鈥檈nregistrement pour les activit茅s qui y sont d茅crites, telles que l鈥櫭﹎ission ou la revente de titres. Aucun indicateur financier suppl茅mentaire, d茅tail de la transaction ou termes de l鈥檕ffre n鈥檃 茅t茅 inclus dans cet avis.
SeaStar Medical Holding Corp (ICU) hat eine formelle Wirksamkeitsmitteilung von der US-B枚rsenaufsichtsbeh枚rde (SEC) erhalten, die best盲tigt, dass die Registrierungsanmeldung Formular S-1 der Gesellschaft (Aktenzeichen 333-288065) am 20. Juni 2025 um 12:00 Uhr ET wirksam wurde. Die Wirksamkeit stellt den letzten regulatorischen Schritt dar, bevor das Unternehmen die Registrierungserkl盲rung f眉r die darin beschriebenen Aktivit盲ten, wie die Ausgabe oder den Wiederverkauf von Wertpapieren, nutzen darf. In dieser Mitteilung wurden keine zus盲tzlichen Finanzkennzahlen, Transaktionsdetails oder Angebotsbedingungen angegeben.
- Form S-1 registration statement declared effective, clearing the way for potential securities issuance or resale.
- None.
Insights
TL;DR: S-1 effectiveness clears regulatory hurdle; modestly positive, enabling potential capital access, but no deal specifics disclosed.
The SEC鈥檚 acknowledgement that SeaStar Medical鈥檚 Form S-1 is now effective removes the last procedural barrier to any securities transactions covered by that filing. While the document itself contains no financial figures, the green light is a prerequisite for capital raising or shareholder resale. For investors, the notice is a routine yet necessary milestone; its impact depends on future offering size, timing and pricing, none of which are available here. Absent those variables, the disclosure is incrementally positive but not yet valuation changing.
TL;DR: Regulatory formality completed; legal clearance achieved, no material risks added or removed.
The SEC鈥檚 Notice of Effectiveness signifies that SeaStar Medical鈥檚 registration statement satisfies disclosure requirements under the Securities Act of 1933. The company may now legally offer or resell registered securities without further SEC review. Because the notice contains no amendments, risk factor changes, or litigation updates, there are no new legal liabilities revealed. From a compliance standpoint, the event is standard and carries neutral-to-positive implications for corporate flexibility.
SeaStar Medical Holding Corp (ICU) ha ricevuto una formale Notifica di Efficacia dalla Securities and Exchange Commission degli Stati Uniti, che conferma che la dichiarazione di registrazione Form S-1 della societ脿 (File No. 333-288065) 猫 diventata efficace il 20 giugno 2025 alle 12:00 p.m. ET. Questa efficacia rappresenta l'ultimo passaggio regolamentare necessario prima che la societ脿 possa utilizzare la dichiarazione di registrazione per le attivit脿 descritte, come l'emissione o la rivendita di titoli. Nessuna metrica finanziaria aggiuntiva, dettagli della transazione o termini dell'offerta sono stati inclusi in questa notifica.
SeaStar Medical Holding Corp (ICU) ha recibido una Notificaci贸n de Efectividad formal de la Comisi贸n de Bolsa y Valores de EE. UU., confirmando que la declaraci贸n de registro Formulario S-1 de la compa帽铆a (Archivo No. 333-288065) se hizo efectiva el 20 de junio de 2025 a las 12:00 p.m. ET. La efectividad marca el 煤ltimo paso regulatorio necesario antes de que la empresa pueda utilizar la declaraci贸n de registro para las actividades descritas, como emitir o revender valores. No se incluyeron m茅tricas financieras adicionales, detalles de la transacci贸n ni t茅rminos de la oferta en esta notificaci贸n.
SeaStar Medical Holding Corp (ICU)電� 氙戈淡 歃濌秾瓯半灅鞙勳洂須�(SEC)搿滊秬韯� 瓿奠嫕鞝侅澑 須牓 韱奠靹�毳� 氚涭晿鞙茧┌, 須岇偓鞚� Form S-1 霌彪 靹滊(韺岇澕 氩堩樃 333-288065)臧� 2025雲� 6鞗� 20鞚� 鞓ろ泟 12鞁�(霃欕秬鞁滉皠)鞐� 須牓鞚� 氚滌儩頄堨潓鞚� 頇曥澑頄堨姷雼堧嫟. 鞚� 須牓 氚滌儩鞚� 須岇偓臧� 頃措嫻 霌彪 靹滊鞐� 氇呾嫓霅� 頇滊彊, 鞓堧ゼ 霌れ柎 歃濌秾 氚滍枆 霕愲姅 鞛寪毵るゼ 歆勴枆頃橁赴 鞝勳棎 頃勳殧頃� 斓滌 攴滌牅 鞝堨皑毳� 鞚橂頃╇媹雼�. 鞚� 韱奠靹滌棎電� 於旉皜 鞛 歆�響�, 瓯半灅 靹鸽秬靷暛 霕愲姅 瓿惦 臁瓣贝鞚� 韽暔霅橃 鞎婌晿鞀惦媹雼�.
SeaStar Medical Holding Corp (ICU) a re莽u une Notification d鈥橢fficacit茅 officielle de la Securities and Exchange Commission des 脡tats-Unis, confirmant que la d茅claration d鈥檈nregistrement Formulaire S-1 de la soci茅t茅 (Dossier n掳 333-288065) est devenue effective le 20 juin 2025 脿 12h00 ET. Cette efficacit茅 marque l鈥櫭﹖ape r茅glementaire finale requise avant que la soci茅t茅 puisse utiliser la d茅claration d鈥檈nregistrement pour les activit茅s qui y sont d茅crites, telles que l鈥櫭﹎ission ou la revente de titres. Aucun indicateur financier suppl茅mentaire, d茅tail de la transaction ou termes de l鈥檕ffre n鈥檃 茅t茅 inclus dans cet avis.
SeaStar Medical Holding Corp (ICU) hat eine formelle Wirksamkeitsmitteilung von der US-B枚rsenaufsichtsbeh枚rde (SEC) erhalten, die best盲tigt, dass die Registrierungsanmeldung Formular S-1 der Gesellschaft (Aktenzeichen 333-288065) am 20. Juni 2025 um 12:00 Uhr ET wirksam wurde. Die Wirksamkeit stellt den letzten regulatorischen Schritt dar, bevor das Unternehmen die Registrierungserkl盲rung f眉r die darin beschriebenen Aktivit盲ten, wie die Ausgabe oder den Wiederverkauf von Wertpapieren, nutzen darf. In dieser Mitteilung wurden keine zus盲tzlichen Finanzkennzahlen, Transaktionsdetails oder Angebotsbedingungen angegeben.
FAQ
What did the SEC declare effective for SeaStar Medical (ICU)?
When did SeaStar Medical鈥檚 S-1 become effective?
What is the SEC file number associated with this filing?
Does the notice include financial terms of any offering?
Why is a Notice of Effectiveness important to investors?
